Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stomach Neoplasms × sintilimab × Clear all

Phase

Status

Unknown 14 Recruiting 9 Not yet recruiting 9 Completed 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Osteosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced or Metastatic Solid Tumors 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Capecitabine 22 Oxaliplatin 19 Fluorouracil 16 pembrolizumab 12 Docetaxel 12 Cisplatin 12 Trastuzumab 10 Leucovorin 10 S 1 (combination) 7 Irinotecan 7 Paclitaxel 6 Epirubicin 6 tegafur-gimeracil-oteracil 4 Cyclophosphamide 4 titanium silicide 3 aldesleukin 3 Surgical Procedures, Operative 3 Hyperthermic Intraperitoneal Chemotherapy 3 vistusertib 2 tislelizumab 2 fludarabine phosphate 2 fludarabine 2 X-Rays 2 Specimen Handling 2 Ramucirumab 2 Platinum 2 Lapatinib 2 Indocyanine Green 2 Folfox protocol 2 Floxuridine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05161572 2025-06-18

NeoRacing

Fudan University

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡